טוען...
Expression of Survivin Does Not Appear to Influence Breast Cancer Recurrence Risk
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells. METHODS: We estimated the association between nuclear and cytoplasmic survivin expression in primary t...
שמור ב:
| הוצא לאור ב: | Acta Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6386593/ https://ncbi.nlm.nih.gov/pubmed/30351173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2018.1503419 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|